Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Pappas Ventures" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Pappas Ventures for you to read. Along with our medical data and news we also list Pappas Ventures Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pappas Ventures Companies for you to search.
Maria Pappashas held the post of Treasurer of Cook Countysince 1998. "During 20 years as treasurer, Pappas has reduced office headcount from 250 Read more...
Pappas: $94 million in property tax refunds available on new website Read more...
Evidation Health Inc. (digital medicines) closed a $15mm Series B round from new backers B Capital Group (lead) and Pappas Ve...
The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Venture Fund also participated in the round.
The round, which was led by HLM Ventures and Optum Ventures, included participation from Centene Corporation, Alma Mundi Ventures and others.
Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic P...
StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) rais...
Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Vent...
Paradromics Inc. (implantable brain-machine interface (BMI) technology) brought in $7mm in a seed financing round co-led by A...
Kickstart Seed Fund led the round, and Purple Arch Ventures, SpringTime Ventures, Service Provider Capital and Lanoha Ventures also participated.
Sutro Biopharma Inc. (oncology) raised $85.4mm through its Series E round. Samsara BioCapital and Surveyor Capital co-led and...
Evolve BioSystems Inc. (develops products to restore and maintain a healthy gut microbiome in infants) raised $40mm in its Se...
A national registry for implantable cardiac defibrillators is expected to be launched by the FDA, said Gregory Pappas, associ -More-
mPulse Mobile, a provider of mobile solutions to drive healthy behavior change has raised $11 million in Series B funding led by SJF Ventures including existing investors HLM Venture Partners, EchoHealth Ventures, OCA Ventures, and Bonfire Ventures. That latest round brings the company’s total funding to date to over $25 million. In addition to the ... Read More
Robotics firm Vicarious Surgical raised $16.75mm in its Series A financing led by Khosla Ventures and Innovation Endeavors, w...
The round was led by Vertex Ventures and Grove Ventures.
MS Ventures is the strategic, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. They invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes. Along with the €100 million MS Ventures fund, their team also manages the €30 million Entrepreneur Partnershi...
Therapeutic antibody developer HiFiBio Therapeutics raised $37.5mm through an oversubscribed Series B round led by Sequoia Ch...
IRW-PRESS: Marapharm Ventures Inc.: Marapharm Ventures Inc. führt Bio-CBD-Gesundheits- und Wellness-Produkte in seiner Ausgabestelle in Kalifornien ein Marapharm Ventures Inc. führt Bio-CBD-Gesund...
Eniac Ventures led the seed round. Nex Cubed, Oronoco Investments, Sway Ventures and Friedman BioVentures also participated.
The financing was led by Third Rock Ventures with participation from GV (formerly Google Ventures), Heritage Provider Network, Casdin Capital, Alexandria Venture Investments and others.
In this interview, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Francesco de Rubertis of Index Ventures, Paul Stoffels, Worldwide Chairman of Johnson & Johnson Pharmaceuticals and Moncef Slaoui, Chairman of Research and Development at GSK about the launch of Index Ventures' new fund, IL